Skip to content
The Kids Research Institute Australia logo

Search

Showing results for "aboriginal respiratory"

Congratulations to Professor Helen Milroy – WA’s 2021 Australian of the Year

The Kids Research Institute Australia congratulates Professor Helen Milroy on being named Western Australia’s 2021 Australian of the Year.

Round one done, eight to go for the SToP Trial

Six weeks, nine community visits and 380 kids – it’s a wrap for round one of the StoP Trial!

Call for Group A streptococcal infections to become notifiable diseases

Researchers at The Kids Research Institute Australia say Group A Streptococcus should become a nationally notifiable disease in Australia.

WA Researchers lead mental health survey of Australia's children

Researchers from Perth's Telethon Institute for Child Health Research will lead a comprehensive national survey of the mental health of Australia's children.

Fetal Alcohol Spectrum Disorder in the Australian Education System: Knowledge, attitudes, needs, and practices

Amy Carol Finlay-Jones Bower BPsych(Hons), MPsych(Clinical), MHealthEcon, PhD (Clin Psych) MBBS MSc PhD FAFPHM DLSHTM FPHA Head, Early

Senior researcher joins Embrace childhood trauma research group

Research Fellow Karen Lombardi recently joined Embrace @ The Kids Research Institute Australia

Embrace 2022 Research Award winners announced

The six winners of the Embrace 2022 Research Awards have been announced.

COVID-19 Research

Thanks to 30 years of support from the WA community, The Kids Research Institute Australia is home to some of the world’s best researchers.

Should Not Anesthesia Research Involve Anesthesiologists? Consequences of the Decline in Academic Anesthesia and Possible Solutions

Britta Regli-von Ungern-Sternberg AM FAHMS MD, PhD, DEAA, FANZA Chair of Paediatric anaesthesia, University of Western Australia; Consultant

Current and novel therapies for management of Acinetobacter baumannii-associated pneumonia

Acinetobacter baumannii is a common pathogen associated with hospital-acquired pneumonia showing increased resistance to carbapenem and colistin antibiotics nowadays. Infections with A. baumannii cause high patient fatalities due to their capability to evade current antimicrobial therapies, emphasizing the urgency of developing viable therapeutics to treat A. baumannii-associated pneumonia.